These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Expression of differentiation antigens on bone marrow myeloid cells of the patients with myelodysplastic syndromes and its clinical significances]. Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):672-7. PubMed ID: 20450725 [TBL] [Abstract][Full Text] [Related]
3. A combination of CD15/CD10, CD64/CD33, CD16/CD13 or CD11b flow cytometric granulocyte panels is sensitive and specific for diagnosis of myelodysplastic syndrome. Chung JW; Park CJ; Cha CH; Cho YU; Jang S; Chi HS; Seo EJ; Lee JH; Lee JH; Lee KH; Im HJ; Seo JJ Ann Clin Lab Sci; 2012; 42(3):271-80. PubMed ID: 22964615 [TBL] [Abstract][Full Text] [Related]
4. Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders. Lorand-Metze I; Ribeiro E; Lima CS; Batista LS; Metze K Leuk Res; 2007 Feb; 31(2):147-55. PubMed ID: 16750852 [TBL] [Abstract][Full Text] [Related]
5. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches. Chopra A; Pati H; Mahapatra M; Mishra P; Seth T; Kumar S; Singh S; Pandey S; Kumar R Ann Hematol; 2012 Sep; 91(9):1351-62. PubMed ID: 22526362 [TBL] [Abstract][Full Text] [Related]
6. Immunophenotype of myeloid granulocytes: a pilot study for distinguishing myelodysplastic syndrome and aplastic anemia by flow cytometry. Huang M; Li J; Zhao G; Sui X; Zhao X; Xu H Int J Lab Hematol; 2010 Jun; 32(3):275-81. PubMed ID: 19968721 [TBL] [Abstract][Full Text] [Related]
7. Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes. Xu F; Li X; Wu L; He Q; Zhang Z; Chang C Br J Haematol; 2010 May; 149(4):587-97. PubMed ID: 20331463 [TBL] [Abstract][Full Text] [Related]
8. Physician Education: Myelodysplastic Syndrome. Yoshida Y Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004 [TBL] [Abstract][Full Text] [Related]
9. Immunophenotype of myeloid cells in myelodysplastic syndromes and its clinical implications. Shao Z; Chen G; Lin Z; Zhang Y; Hao Y; Chu Y; Zheng Y; Qian L; Yang T; Yang C; Feng B Chin Med J (Engl); 1998 Jan; 111(1):28-31. PubMed ID: 10322648 [TBL] [Abstract][Full Text] [Related]
10. Detection of molecular targets on the surface of CD34+CD38- bone marrow cells in myelodysplastic syndromes. Xie W; Wang X; Du W; Liu W; Qin X; Huang S Cytometry A; 2010 Sep; 77(9):840-8. PubMed ID: 20662087 [TBL] [Abstract][Full Text] [Related]
11. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes. Maratheftis CI; Bolaraki PE; Voulgarelis M Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514 [TBL] [Abstract][Full Text] [Related]
12. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes. Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A Cytometry B Clin Cytom; 2005 Mar; 64(1):9-17. PubMed ID: 15668954 [TBL] [Abstract][Full Text] [Related]
13. [Study on the immunophenotypes of bone marrow cells from patients with myelodysplastic syndromes and its clinical implications]. Wang JY; Li XM; Li FJ; Chen XG Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Apr; 10(2):173-4. PubMed ID: 12513825 [TBL] [Abstract][Full Text] [Related]
14. Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes. Mathis S; Chapuis N; Debord C; Rouquette A; Radford-Weiss I; Park S; Dreyfus F; Lacombe C; Béné MC; Kosmider O; Fontenay M; Bardet V Leukemia; 2013 Oct; 27(10):1981-7. PubMed ID: 23765225 [TBL] [Abstract][Full Text] [Related]
15. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome. Schlesinger M; Silverman LR; Jiang JD; Yagi MJ; Holland JF; Bekesi JG J Clin Lab Immunol; 1996; 48(4):149-66. PubMed ID: 9819667 [TBL] [Abstract][Full Text] [Related]
16. [Differentiation and expression of membrane hemopoietic cytokine receptors on CD34+ bone marrow cells in patients with myelodysplastic syndromes]. Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):234-8. PubMed ID: 21418866 [TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromes. Xu F; Wu L; He Q; Zhang Z; Chang C; Li X Intern Med J; 2012 Apr; 42(4):401-11. PubMed ID: 22032631 [TBL] [Abstract][Full Text] [Related]
18. [Application of flow cytometry in detecting dysplasia of myelodysplastic syndromes]. Li J; He GS Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1069-72. PubMed ID: 23998614 [TBL] [Abstract][Full Text] [Related]
20. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases]. Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]